NCT06032260

Brief Summary

The aim of the present pilot randomized controlled trial is to compare the effects of the following: 1)-panettone enriched with arabinoxylans (p-rich), 2)-panettone not enriched (p-standard) on blood glucose and insulin values, and appetite scores in 10 healthy volunteers.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable healthy

Timeline
Completed

Started Jan 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 20, 2023

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2023

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

August 31, 2023

Completed
11 days until next milestone

First Posted

Study publicly available on registry

September 11, 2023

Completed
Last Updated

September 13, 2023

Status Verified

September 1, 2023

Enrollment Period

5 months

First QC Date

August 31, 2023

Last Update Submit

September 11, 2023

Conditions

Keywords

Arabinoxylanfiber-enriched productglycemiainsulinappetite

Outcome Measures

Primary Outcomes (1)

  • Changes in circulating concentrations of glucose

    To evaluate changes in glucose responses after the consumption of p-rich when compared to p-standard

    15, 30, 45, 60, 90, 120 minutes after the consumption of each food

Secondary Outcomes (2)

  • Changes in circulating concentrations of insulin

    15, 30, 45, 60, 90, 120 minutes after the consumption of each food

  • Changes in subjective appetite score (VAS)

    60, 120, 180, and 240 minutes after the consumption of each food

Study Arms (2)

Enriched panettone

EXPERIMENTAL

100 grams of panettone enriched with fiber. The added fiber is JAX Plus® (Heallo srl, Milano, Italy), a soluble fiber with Arabinoxylans from wheat and barley

Other: Enriched panettone

Panettone standard

ACTIVE COMPARATOR

100 grams of panettone without fiber enrichment

Other: Panettone standard

Interventions

Volunteers consumed 100 grams of panettone enriched with fiber (JAX Plus® (Heallo srl, Milano, Italy), a soluble fiber with Arabinoxylans from wheat and barley

Enriched panettone

Volunteers consumed 100 grams of panettone standard

Panettone standard

Eligibility Criteria

Age20 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • non-smokers healthy adults;
  • age 20-65 years;
  • ability to provide informed written consent

You may not qualify if:

  • obesity;
  • chronic diseases or pharmacological therapies;
  • dietary restrictions;
  • allergy or intolerance to the tested food

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Turin

Turin, AT, 10126, Italy

Location

MeSH Terms

Conditions

Insulin Resistance

Condition Hierarchy (Ancestors)

HyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Neither the participant nor the investigators were aware of the composition of the administered food. The two types of foods were identical for packages, color, flavor, smell, and appearance. Furthermore, the researchers who analyzed data and the laboratory personnel who performed the biochemical analyses were blinded to the group assigned.
Purpose
PREVENTION
Intervention Model
CROSSOVER
Model Details: crossover randomized double-blind trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

August 31, 2023

First Posted

September 11, 2023

Study Start

January 20, 2023

Primary Completion

June 30, 2023

Study Completion

July 30, 2023

Last Updated

September 13, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

Locations